Bacterial drug resistance is one of the hot spots in the 21st century. At least 700 000 people die from drug-resistant bacteria causing diseases every year, and drug resistance has created a huge economic and health burden. In recent years, in order to delay the process of bacterial drug resistance, under the guidance and promotion of government policies, the scientific community and the academic community have made joint efforts. At present, a variety of new antimicrobial agents have been developed in different stages of research or have been marketed. This present article briefly reviewed the drugs that had been marketed and are in phase Ⅲ clinical studies in recent years, and mainly used for the treatment of drug-resistant bacterial infections and new non-traditional antimicrobial agent substitutes. In order to provide reference for related research and clinical application, the relevant pharmacology, clinical studies and safety of the drug were introduced.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |